Home/Filings/4/0001600132-17-000067
4//SEC Filing

Bellerophon Therapeutics, Inc. 4

Accession 0001600132-17-000067

CIK 0001600132operating

Filed

Jun 29, 8:00 PM ET

Accepted

Jun 30, 6:44 PM ET

Size

4.5 KB

Accession

0001600132-17-000067

Insider Transaction Report

Form 4
Period: 2017-06-28
Luehring Jens
Director10% Owner
Transactions
  • Award

    Common Stock

    2017-06-28+30,79870,658 total

Issuer

Bellerophon Therapeutics, Inc.

CIK 0001600132

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001600132

Filing Metadata

Form type
4
Filed
Jun 29, 8:00 PM ET
Accepted
Jun 30, 6:44 PM ET
Size
4.5 KB